The Risk of Early Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C-Infected Patients Treated With Direct-Acting Antivirals With and Without Pegylated Interferon: A Belgian Experience

Journal of Viral Hepatitis - United Kingdom
doi 10.1111/jvh.12726
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Increased Incidence or Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients Treated With Direct-Acting Antivirals: Myth or Fact?

Expert Review of Anticancer Therapy
OncologyPharmacology
2018English

Direct-Acting Antivirals and Recurrence of Hepatocellular Carcinoma

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Unexpected Viral Relapses in Hepatitis C Virus-Infected Patients Diagnosed With Hepatocellular Carcinoma During Treatment With Direct-Acting Antivirals

Hepatology
MedicineHepatology
2017English

Hepatitis B Reactivation in Chronic Hepatitis C Patients Treated With Interferon or Pan-Oral Direct-Acting Antivirals

Hepatology
MedicineHepatology
2017English

Hepatitis C Related Hepatocellular Carcinoma in the Era of Direct-Acting Antivirals

Hepatoma Research
2018English

The Interplay Between Direct-Acting Antivirals and Hepatocellular Carcinoma in Chronic Hepatitis C

Hepatoma Research
2020English

Infection Route of Hepatitis C Patients Treated With Direct-Acting Antivirals -To Evaluate the Risk of Reinfection-

Acta Hepatologica Japonica
Hepatology
2017English

Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Virus Therapy With Direct-Acting Antivirals

Journal of Hepatology
Hepatology
2017English

Concomitant Use of Direct-Acting Antivirals and Chemotherapy in Hepatitis C Virus-Infected Patients With Cancer

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy